These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25606592)

  • 1. Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer.
    Pal A; Donato NJ
    Breast Cancer Res; 2014; 16(5):461. PubMed ID: 25606592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
    Crosas B
    Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis.
    Zhang X; Jin J; Cong J; Chen S; Wang T; Gao B; Huang G; Huang Z; Zhang J; Wang Z; Yang J
    Curr Top Med Chem; 2024; 24(3):179-191. PubMed ID: 38173207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.
    Pal A; Young MA; Donato NJ
    Cancer Res; 2014 Sep; 74(18):4955-66. PubMed ID: 25172841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase inhibition as a cancer therapeutic strategy.
    D'Arcy P; Wang X; Linder S
    Pharmacol Ther; 2015 Mar; 147():32-54. PubMed ID: 25444757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.
    Chen S; Liu Y; Zhou H
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells.
    Vogel RI; Coughlin K; Scotti A; Iizuka Y; Anchoori R; Roden RB; Marastoni M; Bazzaro M
    Oncotarget; 2015 Feb; 6(6):4159-70. PubMed ID: 25784654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinases in cancer.
    Wei R; Liu X; Yu W; Yang T; Cai W; Liu J; Huang X; Xu GT; Zhao S; Yang J; Liu S
    Oncotarget; 2015 May; 6(15):12872-89. PubMed ID: 25972356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.
    Gao H; Xi Z; Dai J; Xue J; Guan X; Zhao L; Chen Z; Xing F
    Mol Cancer; 2024 May; 23(1):88. PubMed ID: 38702734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ubiquitin-specific peptidases in cancer progression.
    Young MJ; Hsu KC; Lin TE; Chang WC; Hung JJ
    J Biomed Sci; 2019 May; 26(1):42. PubMed ID: 31133011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitinases and the new therapeutic opportunities offered to cancer.
    Pfoh R; Lacdao IK; Saridakis V
    Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics.
    Lill JR; Wertz IE
    Trends Pharmacol Sci; 2014 Apr; 35(4):187-207. PubMed ID: 24717260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
    Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
    Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-specific proteases as cancer drug targets.
    Sippl W; Collura V; Colland F
    Future Oncol; 2011 May; 7(5):619-32. PubMed ID: 21568678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways: translational potential of deubiquitinases as drug targets.
    D'Arcy P; Linder S
    Clin Cancer Res; 2014 Aug; 20(15):3908-14. PubMed ID: 25085788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Deubiquitinating Enzymes in DNA Repair.
    Kee Y; Huang TT
    Mol Cell Biol; 2016 Feb; 36(4):524-44. PubMed ID: 26644404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Selective Inhibitor of Ubiquitin-Specific Protease 4 Suppresses Colorectal Cancer Progression by Regulating β-Catenin Signaling.
    Nguyen HH; Kim T; Nguyen T; Hahn MJ; Yun SI; Kim KK
    Cell Physiol Biochem; 2019; 53(1):157-171. PubMed ID: 31251006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases.
    Chou CK; Chang YT; Korinek M; Chen YT; Yang YT; Leu S; Lin IL; Tang CJ; Chiu CC
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating enzymes in cellular signaling and disease regulation.
    Hanpude P; Bhattacharya S; Dey AK; Maiti TK
    IUBMB Life; 2015 Jul; 67(7):544-55. PubMed ID: 26178252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.